Context:
Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors for kidney disease have not been well studied.
Objective:
To identify predictors of the development of new-onset kidney disease.
Design, Setting, And Participants:
A community-based, longitudinal cohort study of 2585 participants who attended both a baseline examination in 1978-1982 and a follow-up examination in 1998-2001, and who were free of kidney disease at baseline.
Main Outcome Measures:
Kidney disease was assessed by the Modification of Diet in Renal Disease Study equation and defined by a glomerular filtration rate (GFR) in the fifth or lower percentile (< or =59.25 mL/min per 1.73 m2 in women, < or =64.25 mL/min per 1.73 m2 in men). Stepwise logistic regression was used to determine the impact of risk factors on the occurrence of new-onset kidney disease. Baseline and long-term, 12-year, averaged risk factor models were explored.
Results:
At baseline, there were 1223 men and 1362 women, with a mean age of 43 years, who were free of preexisting kidney disease. After a mean follow-up of 18.5 years, 244 participants (9.4%) had developed kidney disease. In multivariable models, baseline age (odds ratio [OR], 2.36 per 10-year increment; 95% confidence interval [CI], 2.00-2.78), GFR (<90 mL/min per 1.73 m2: OR, 3.01; 95% CI, 1.98-4.58; 90-119 mL/min per 1.73 m2: OR, 1.84; 95% CI, 1.16-2.93), body mass index (OR, 1.23 per 1 SD; 95% CI, 1.08-1.41), diabetes (OR, 2.60; 95% CI, 1.44-4.70), and smoking (OR, 1.42; 95% CI, 1.06-1.91) were related to the development of kidney disease. In addition to baseline age and GFR, the long-term, averaged risk factors that were predictive of kidney disease included hypertension (OR, 1.57; 95% CI, 1.17-2.12), high-density lipoprotein cholesterol level (OR, 0.80 per 1 SD; 95% CI, 0.69-0.92), and diabetes (OR, 2.38; 95% CI, 1.45-3.92). Compared with a normal GFR (> or =120 mL/min per 1.73 m2), a mildly reduced GFR (<90 mL/min per 1.73 m2) predicted a 3-fold odds of progression to kidney disease (OR, 2.95; 95% CI, 1.94-4.49).
Conclusions:
Established cardiovascular disease risk factors are associated with the development of new-onset kidney disease. Patients with a mildly reduced GFR should be monitored for progression to kidney disease.
Citing Articles
Age, creatinine, and ejection fraction score is a risk factor for acute kidney injury after surgical aortic valve replacement.
Wu T, Li R, Chen J, Tian X, Zhang R, Hou X
Ren Fail. 2025; 47(1):2444401.
PMID: 39806782
PMC: 11734393.
DOI: 10.1080/0886022X.2024.2444401.
Development of a machine learning tool to predict the risk of incident chronic kidney disease using health examination data.
Yoshizaki Y, Kato K, Fujihara K, Sone H, Akazawa K
Front Public Health. 2024; 12:1495054.
PMID: 39555038
PMC: 11566449.
DOI: 10.3389/fpubh.2024.1495054.
Serum Osmolality as a Predictor of Renal Function Decline: A Retrospective Cohort Study.
Wu J, Tung C, Lin C, Huang J, Yang J, Tsai Y
J Clin Med. 2024; 13(21).
PMID: 39518643
PMC: 11545865.
DOI: 10.3390/jcm13216505.
Association of Smoking with Chronic Kidney Disease Stages 3 to 5: A Mendelian Randomization Study.
Zhang Z, Zhang F, Zhang X, Lu L, Zhang L
Health Data Sci. 2024; 4:0199.
PMID: 39498379
PMC: 11532587.
DOI: 10.34133/hds.0199.
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology.
Zeravica R, Ilincic B, Buric D, Jakovljevic A, Crnobrnja V, Ilic D
Int J Mol Sci. 2024; 25(20).
PMID: 39456940
PMC: 11509006.
DOI: 10.3390/ijms252011159.
Impact of metabolic abnormalities on the association between normal-range urinary albumin-to-creatinine ratio and cardiovascular mortality: evidence from the NHANES 1999-2018.
Li M, Ji R, Li Z, Zhao S, Liu R, Liu X
Diabetol Metab Syndr. 2024; 16(1):250.
PMID: 39434188
PMC: 11495052.
DOI: 10.1186/s13098-024-01488-5.
Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction.
Lim K, Nayor M, Arroyo E, Burney H, Li X, Li Y
Clin J Am Soc Nephrol. 2024; 19(12):1547-1561.
PMID: 39401313
PMC: 11637711.
DOI: 10.2215/CJN.0000000000000548.
Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society....
Annunziata G, Caprio M, Verde L, Carella A, Camajani E, Benvenuto A
J Endocrinol Invest. 2024; 47(12):2889-2913.
PMID: 39292364
DOI: 10.1007/s40618-024-02446-8.
Association between visceral adiposity index and incidence of diabetic kidney disease in adults with diabetes in the United States.
Li C, Wang G, Zhang J, Jiang W, Wei S, Wang W
Sci Rep. 2024; 14(1):17957.
PMID: 39095646
PMC: 11297263.
DOI: 10.1038/s41598-024-69034-x.
Acute and chronic complication profiles among patients with chronic kidney disease in Alberta, Canada: a retrospective observational study.
Lau D, Shaw E, McMullen S, Cowling T, Witges K, Amitay E
BMC Nephrol. 2024; 25(1):244.
PMID: 39080608
PMC: 11288078.
DOI: 10.1186/s12882-024-03682-z.
Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication.
Ma X, Lv J, Zhang S, Zhang X, Lin X, Li S
Nutrients. 2024; 16(14).
PMID: 39064798
PMC: 11279651.
DOI: 10.3390/nu16142355.
One anastomosis gastric bypass ameliorates diabetic nephropathy via regulating the GLP-1-mediated Sirt1/AMPK/PGC1α pathway.
Han L, Chen X, Wan D, Xie M, Ouyang S
Clin Exp Nephrol. 2024; 28(10):1051-1061.
PMID: 38782822
DOI: 10.1007/s10157-024-02516-4.
Associations between the Serum Triglyceride Level and Kidney Outcome in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry Study.
Seki M, Nakano T, Tanaka S, Kitamura H, Hiyamuta H, Ninomiya T
J Atheroscler Thromb. 2024; 31(11):1556-1570.
PMID: 38735756
PMC: 11537783.
DOI: 10.5551/jat.64625.
Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate.
Jairoun A, Ping C, Ibrahim B
Sci Rep. 2024; 14(1):9014.
PMID: 38641627
PMC: 11031608.
DOI: 10.1038/s41598-024-58574-x.
Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis.
Weon B, Jang Y, Jo J, Jin W, Ha S, Ko A
PLoS One. 2024; 19(4):e0299605.
PMID: 38626061
PMC: 11020804.
DOI: 10.1371/journal.pone.0299605.
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD).
Ali M, Parveen S, Williams V, Dons R, Uwaifo G
J Clin Transl Endocrinol. 2024; 36:100341.
PMID: 38616864
PMC: 11015524.
DOI: 10.1016/j.jcte.2024.100341.
Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.
Jairoun A, Al-Hemyari S, Shahwan M, Zyoud S, El-Dahiyat F
Sci Rep. 2024; 14(1):7284.
PMID: 38538618
PMC: 10973329.
DOI: 10.1038/s41598-024-56765-0.
Health Literacy, Self-Care Behaviors, and Biochemical Parameters Among Hypertensive Patients with Renal Complications in the Tai Lue Ethnic Community of Thailand.
Sriprachot N, Seangpraw K, Ong-Artborirak P
Vasc Health Risk Manag. 2024; 20:97-107.
PMID: 38464676
PMC: 10922938.
DOI: 10.2147/VHRM.S450775.
Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?.
Farrell D, Vassalotti J
BMC Nephrol. 2024; 25(1):34.
PMID: 38273240
PMC: 10809507.
DOI: 10.1186/s12882-024-03466-5.
Association Between Cardiovascular Disease and Chronic Kidney Disease Prevalence and Characteristics in Saudi Arabia.
Elheet A, Alosaimi M, Alalawi W, Alasmari A, Alharbi A, Alhumaidan L
Cureus. 2024; 15(12):e50205.
PMID: 38192962
PMC: 10772358.
DOI: 10.7759/cureus.50205.